Institute for Medical Information Processing, Biometry and Epidemiology, Ludwig Maximilians University Munich, Munich, Germany
Pettenkofer School of Public Health, Ludwig Maximilians University Munich, Munich, Germany.
BMJ Open. 2021 Apr 9;11(4):e041619. doi: 10.1136/bmjopen-2020-041619.
To comprehensively map the existing evidence assessing the impact of travel-related control measures for containment of the SARS-CoV-2/COVID-19 pandemic.
Rapid evidence map.
MEDLINE, Embase and Web of Science, and COVID-19 specific databases offered by the US Centers for Disease Control and Prevention and the WHO.
We included studies in human populations susceptible to SARS-CoV-2/COVID-19, SARS-CoV-1/severe acute respiratory syndrome, Middle East respiratory syndrome coronavirus/Middle East respiratory syndrome or influenza. Interventions of interest were travel-related control measures affecting travel across national or subnational borders. Outcomes of interest included infectious disease, screening, other health, economic and social outcomes. We considered all empirical studies that quantitatively evaluate impact available in Armenian, English, French, German, Italian and Russian based on the team's language capacities.
We extracted data from included studies in a standardised manner and mapped them to a priori and (one) post hoc defined categories.
We included 122 studies assessing travel-related control measures. These studies were undertaken across the globe, most in the Western Pacific region (n=71). A large proportion of studies focused on COVID-19 (n=59), but a number of studies also examined SARS, MERS and influenza. We identified studies on border closures (n=3), entry/exit screening (n=31), travel-related quarantine (n=6), travel bans (n=8) and travel restrictions (n=25). Many addressed a bundle of travel-related control measures (n=49). Most studies assessed infectious disease (n=98) and/or screening-related (n=25) outcomes; we found only limited evidence on economic and social outcomes. Studies applied numerous methods, both inferential and descriptive in nature, ranging from simple observational methods to complex modelling techniques.
We identified a heterogeneous and complex evidence base on travel-related control measures. While this map is not sufficient to assess the effectiveness of different measures, it outlines aspects regarding interventions and outcomes, as well as study methodology and reporting that could inform future research and evidence synthesis.
全面绘制现有的评估旅行相关控制措施对遏制 SARS-CoV-2/COVID-19 大流行影响的证据。
快速证据图。
MEDLINE、Embase 和 Web of Science,以及美国疾病控制与预防中心和世界卫生组织提供的 COVID-19 特定数据库。
我们纳入了易感染 SARS-CoV-2/COVID-19、SARS-CoV-1/严重急性呼吸综合征、中东呼吸综合征冠状病毒/中东呼吸综合征或流感的人群的研究。感兴趣的干预措施是影响跨国或跨国界旅行的旅行相关控制措施。感兴趣的结果包括传染病、筛查、其他健康、经济和社会结果。我们考虑了根据团队的语言能力,以亚美尼亚语、英语、法语、德语、意大利语和俄语提供的定量评估影响的所有实证研究。
我们以标准化的方式从纳入的研究中提取数据,并将其映射到事先和(一个)事后定义的类别。
我们纳入了 122 项评估旅行相关控制措施的研究。这些研究在全球范围内进行,其中大部分在西太平洋地区(n=71)。很大一部分研究集中在 COVID-19(n=59)上,但也有一些研究考察了 SARS、MERS 和流感。我们确定了关于边境关闭(n=3)、入境/出境筛查(n=31)、旅行相关检疫(n=6)、旅行禁令(n=8)和旅行限制(n=25)的研究。许多研究涉及一揽子旅行相关控制措施(n=49)。大多数研究评估了传染病(n=98)和/或筛查相关(n=25)的结果;我们只发现了有限的关于经济和社会结果的证据。研究应用了许多方法,包括推理和描述性的,从简单的观察方法到复杂的建模技术。
我们确定了关于旅行相关控制措施的异质性和复杂的证据基础。虽然这张地图不足以评估不同措施的有效性,但它概述了干预措施和结果,以及研究方法和报告,这些都可以为未来的研究和证据综合提供信息。